AI for Science

Explore AI for Science through related topics and the articles other pages reference most.

Explore articles

Reset filters
Browse subtopics: Healthcare AI

Articles that also belong to these categories. Counts cover all of AI for Science.

Showing 1-12 of 12 articles

AlphaGenome

AlphaGenome is a unified deep learning model developed by Google DeepMind that predicts thousands of functional genomic properties from raw DNA sequences.

AI ModelsGoogle DeepMind

AlphaMissense

AlphaMissense is a machine learning model from Google DeepMind that predicts whether a missense variant, a single amino-acid substitution in a protein, is likely to cause disease.

Google DeepMindHealthcare AI

Brain-Computer Interface

A brain-computer interface (BCI), also called a brain-machine interface, is a system that measures activity in the nervous system and translates it into commands for an external device, bypassing muscles and…

AI CompaniesDeep Learning

C-BRAIN

C-BRAIN (the Consortium for Biomedical Research and AI in Neurodegeneration, styled "C-brAIn" in early coverage) is a consortium of academic researchers, pharmaceutical companies, philanthropic organizations…

Healthcare AIOpen Source AI

NewLimit

NewLimit is an American biotechnology company, headquartered in South San Francisco, California, that is developing medicines intended to restore youthful function to old cells through epigenetic reprogramming.

AI CompaniesDrug Discovery

Protein design

Protein design is the construction of new protein sequences that fold into an intended three-dimensional shape and perform an intended job, such as binding a chosen target, catalyzing a reaction, or assembling…

Drug DiscoveryHealthcare AI

Rentosertib

Rentosertib is an investigational oral small-molecule inhibitor of TNIK (TRAF2- and NCK-interacting kinase) developed by Insilico Medicine for idiopathic pulmonary fibrosis (IPF)

Drug DiscoveryHealthcare AI

Virtual Biology Initiative

The Virtual Biology Initiative is a five-year research program launched on April 29, 2026 by Biohub, the science organization of the Chan Zuckerberg Initiative (CZI), with a founding commitment of $500 million.

Healthcare AI